New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > NEKTAR THERAPEUTICS
NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq ・ Market Cap: Micro
CEO Recent Sales
Top Executive Recent Sales
Regular Sale Insiders
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 20 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 5 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 478,507 0 / 23,925 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $537,421 $0 / $26,871 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $5,172.08 - $132,030 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
50.49%
DIRECTORS
36.83%
OFFICERS
12.67%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.324 0.295 |
VALUE GINI INDEX Sector Average | 0.372 0.288 |
NEKTAR THERAPEUTICS 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2025-02-21 2025-02-19 | Zalevsky Jonathan | Officer | -$10,403 | 10,300 | $1.01 | -3.15% | 316,604 | N/A | N/A | |
2025-02-21 2025-02-19 | Wilson Mark Andrew | Officer | -$11,150 | 11,040 | $1.01 | -3.29% | 324,292 | N/A | N/A | |
2025-02-21 2025-02-19 | ROBIN HOWARD W | Director | -$24,012 | 23,774 | $1.01 | -2.14% | 1,087,311 | N/A | N/A | |
2024-12-26 2024-12-23 | Wilson Mark Andrew | Officer | -$44,966 | 49,962 | $0.9 | -12.97% | 335,332 | N/A | N/A | |
2024-12-20 2024-12-19 | Zalevsky Jonathan | Officer | -$48,048 | 51,115 | $0.94 | -13.52% | 326,904 | N/A | N/A | |
2024-12-19 2024-12-17 | ROBIN HOWARD W | Director | -$132,030 | 132,030 | $1 | -10.62% | 1,111,085 | N/A | N/A | |
2024-11-20 2024-11-19 | Zalevsky Jonathan | Officer | -$7,863 | 7,785 | $1.01 | -3.1% | 243,019 | +1.00% | +13.00% | |
2024-11-20 2024-11-19 | Wilson Mark Andrew | Officer | -$6,471 | 6,407 | $1.01 | -2.84% | 218,856 | +1.00% | +13.00% | |
2024-11-20 2024-11-19 | ROBIN HOWARD W | Director | -$16,441 | 16,278 | $1.01 | -1.92% | 832,490 | +1.00% | +13.00% | |
2024-08-20 2024-08-19 | Zalevsky Jonathan | Officer | -$8,788 | 6,866 | $1.28 | -2.66% | 250,804 | -0.78% | -2.34% |